Houlihan Lokey Advises ReMed Recovery Care Centers
Houlihan Lokey is pleased to announce that ReMed Recovery Care Centers (ReMed), a portfolio company of Bregal Partners, has been acquired by Baird Capital. The transaction closed on February 2, 2018.
ReMed is a top five national provider of treatment for individuals with traumatic brain injuries (TBI) and number one in the mid-Atlantic market.
Headquartered in Paoli, Pennsylvania, ReMed was founded in 1984 under the single premise that individuals with brain injury have the potential to return to a life that is meaningful and productive. ReMed’s extensive continuum of care allows access at varying levels and stages of recovery, whether the injury is mild, moderate, or severe. ReMed’s treatment philosophy has since become a standard of care for post-acute brain injury treatment. Today, ReMed serves more than 300 individuals in the states of Pennsylvania, New Jersey, Maryland, and Louisiana in short-term, long-term, and outpatient programs.
Bregal Partners is a leading middle-market private equity firm with a focus on corporate social responsibility. The firm looks to acquire and grow market-leading businesses in the consumer, food, multi-unit, and energy services industries. Bregal Partners is one of several dedicated firms under the Bregal Investments umbrella, which is a global private equity platform that has invested or committed more than $12.5 billion since 2002.
Baird Capital makes venture capital, growth equity, and private equity investments in strategically targeted sectors around the world. Having invested in more than 300 companies over its history, Baird Capital partners with entrepreneurs and, leveraging its executive networks, strives to build exceptional companies. Baird Capital provides operational support to its portfolio companies through teams on the ground in the United States, Europe, and Asia; a proactive portfolio operations team; and a deep network of relationships, which together strive to deliver enhanced shareholder value. Baird Capital is the direct private investment arm of Robert W. Baird & Co.
Houlihan Lokey is a premier advisor to healthcare companies, with more than 120 closed transactions since 2014. This most recent transaction further strengthens Houlihan Lokey's leadership in the healthcare sector and highlights the firm’s continued momentum in the multi-site healthcare services space.
RELATED: Healthcare